Ligand validation:1GCO

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1GCO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1GCO_NAD_A_601	86%	10%	0.084	0.952	2.43	1.91	10	8	2	0	100%	1
1GCO_NAD_B_701	83%	10%	0.089	0.947	2.43	1.89	10	8	2	0	100%	1
1GCO_NAD_F_901	81%	10%	0.09	0.94	2.43	1.9	10	7	2	0	100%	1
1GCO_NAD_E_801	80%	10%	0.089	0.938	2.4	1.87	10	8	1	0	100%	1
1GEE_NAD_B_2262	86%	14%	0.08	0.948	2.14	1.72	9	8	2	0	100%	1
1G6K_NAD_B_2262	61%	13%	0.121	0.91	2.21	1.76	7	9	1	0	100%	1
1RWB_NAD_A_601	54%	14%	0.128	0.892	2.18	1.73	8	9	3	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.